138 related articles for article (PubMed ID: 16731597)
1. Clinical significance of plasmacytosis in the day+14 bone marrow of patients with acute myeloid leukaemia undergoing induction chemotherapy.
Al-Shughair N; Al-Dawsari G; Gyger M; Mohamed G; Roberts G
J Clin Pathol; 2007 May; 60(5):520-3. PubMed ID: 16731597
[TBL] [Abstract][Full Text] [Related]
2. Early blast clearance by remission induction therapy is a major independent prognostic factor for both achievement of complete remission and long-term outcome in acute myeloid leukemia: data from the German AML Cooperative Group (AMLCG) 1992 Trial.
Kern W; Haferlach T; Schoch C; Loffler H; Gassmann W; Heinecke A; Sauerland MC; Berdel W; Buchner T; Hiddemann W
Blood; 2003 Jan; 101(1):64-70. PubMed ID: 12393605
[TBL] [Abstract][Full Text] [Related]
3. Bone marrow microvessel density and its prognostic significance in AML.
Rabitsch W; Sperr WR; Lechner K; Chott A; Prinz E; Valent P; Kalhs P
Leuk Lymphoma; 2004 Jul; 45(7):1369-73. PubMed ID: 15359635
[TBL] [Abstract][Full Text] [Related]
4. Monitoring of minimal residual disease in adult acute myeloid leukemia using peripheral blood as an alternative source to bone marrow.
Maurillo L; Buccisano F; Spagnoli A; Del Poeta G; Panetta P; Neri B; Del Principe MI; Mazzone C; Consalvo MI; Tamburini A; Ottaviani L; Fraboni D; Sarlo C; De Fabritiis P; Amadori S; Venditti A
Haematologica; 2007 May; 92(5):605-11. PubMed ID: 17488683
[TBL] [Abstract][Full Text] [Related]
5. Remission induction chemotherapy induces in vivo caspase-dependent apoptosis in bone marrow acute myeloid leukemia blast cells and spares lymphocytes.
Vial JP; Tabrizi R; Pigneux A; Lacombe F; Praloran V; Belloc F
Cytometry B Clin Cytom; 2006 May; 70(3):115-23. PubMed ID: 16572429
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of residual disease during treatment in childhood acute myeloid leukaemia.
Coustan-Smith E; Ribeiro RC; Rubnitz JE; Razzouk BI; Pui CH; Pounds S; Andreansky M; Behm FG; Raimondi SC; Shurtleff SA; Downing JR; Campana D
Br J Haematol; 2003 Oct; 123(2):243-52. PubMed ID: 14531905
[TBL] [Abstract][Full Text] [Related]
7. Analysis of hematogones in bone marrow from acute myeloid leukaemia cases posttherapy.
Zheng J; Du W; Yao J; You Y; Li W; He Y; Li X; Liu W; Wu Y; Hu Y; Jin R; Zou P; Huang S; Hu Y; Zhang M
Eur J Clin Invest; 2013 Nov; 43(11):1140-6. PubMed ID: 23992300
[TBL] [Abstract][Full Text] [Related]
8. Impact of Day 14 Bone Marrow Biopsy on Re-Induction Decisions and Prediction of a Complete Response in Acute Myeloid Leukemia Cases.
Alsaleh K; Aleem A; Almomen A; Anjum F; S Alotaibi G
Asian Pac J Cancer Prev; 2018 Feb; 19(2):421-425. PubMed ID: 29479992
[TBL] [Abstract][Full Text] [Related]
9. [Detection of residual leukemic cells after complete remission of patients with acute myeloid leukemia].
Xu YL; Zhang XZ; Zhang L; Zhang XQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Dec; 12(6):858-60. PubMed ID: 15631679
[TBL] [Abstract][Full Text] [Related]
10. Low L-selectin (CD62L) expression in acute myeloid leukemia correlates with a bad cytogenetic risk.
Graf M; Reif S; Hecht K; Pelka-Fleischer R; Pfister K; Nuessler V; Schmetzer H
Eur J Haematol; 2003 Nov; 71(5):366-76. PubMed ID: 14667200
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of day 14 bone marrow evaluation in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia.
Short NJ; Kantarjian HM; Sasaki K; Cortes JE; Ravandi F; Thomas DA; Garcia-Manero G; Khouri I; Kebriaei P; Champlin RE; Pierce S; Issa GC; Konopleva M; Kadia TM; Bueso-Ramos C; Khoury JD; Jain N; O'Brien SM; Jabbour E
Cancer; 2016 Dec; 122(24):3812-3820. PubMed ID: 27508525
[TBL] [Abstract][Full Text] [Related]
12. Prognostic variables in newly diagnosed children and adolescents with acute myeloid leukemia: Children's Cancer Group Study 213.
Wells RJ; Arthur DC; Srivastava A; Heerema NA; Le Beau M; Alonzo TA; Buxton AB; Woods WG; Howells WB; Benjamin DR; Betcher DL; Buckley JD; Feig SA; Kim T; Odom LF; Ruymann FB; Smithson WA; Tannous R; Whitt JK; Wolff L; Tjoa T; Lampkin BC
Leukemia; 2002 Apr; 16(4):601-7. PubMed ID: 11960339
[TBL] [Abstract][Full Text] [Related]
13. Colony growth in cultures from bone marrow and peripheral blood after curative treatment for leukemia and severe aplastic anemia.
Betticher DC; Huxol H; Müller R; Speck B; Nissen C
Exp Hematol; 1993 Nov; 21(12):1517-21. PubMed ID: 8405233
[TBL] [Abstract][Full Text] [Related]
14. Dysmegakaryopoiesis predicting response to therapy in acute myeloid leukaemia. A histologic and clinical study.
Delacrétaz F; Spertini O; Schmidt PM; Grob JP
Pathol Res Pract; 1991 Mar; 187(2-3):290-5. PubMed ID: 2068013
[TBL] [Abstract][Full Text] [Related]
15. Pretreatment leukaemia cell drug resistance is correlated to clinical outcome in acute myeloid leukaemia.
Nørgaard JM; Langkjer ST; Palshof T; Pedersen B; Hokland P
Eur J Haematol; 2001 Mar; 66(3):160-7. PubMed ID: 11350484
[TBL] [Abstract][Full Text] [Related]
16. Long-term outcomes of myeloablation and autologous transplantation of relapsed acute myeloid leukemia in second remission: a British Society of Blood and Marrow Transplantation registry study.
Chantry AD; Snowden JA; Craddock C; Peggs K; Roddie C; Craig JI; Orchard K; Towlson KE; Pearce RM; Marks DI;
Biol Blood Marrow Transplant; 2006 Dec; 12(12):1310-7. PubMed ID: 17162213
[TBL] [Abstract][Full Text] [Related]
17. The effect of allogeneic stem cell transplantation on outcome in younger acute myeloid leukemia patients with minimal residual disease detected by flow cytometry at the end of post-remission chemotherapy.
Laane E; Derolf AR; Björklund E; Mazur J; Everaus H; Söderhäll S; Björkholm M; Porwit-MacDonald A
Haematologica; 2006 Jun; 91(6):833-6. PubMed ID: 16769587
[TBL] [Abstract][Full Text] [Related]
18. The selective use of AMSA following high-dose cytarabine in patients with acute myeloid leukaemia in relapse: a Leukemia Intergroup study.
Larson RA; Day RS; Azarnia N; Bennett JM; Browman G; Goldberg J; Gottlieb A; Grunwald H; Miller K; Raza A
Br J Haematol; 1992 Oct; 82(2):337-46. PubMed ID: 1419816
[TBL] [Abstract][Full Text] [Related]
19. Increased angiogenesis in the bone marrow of patients with acute myeloid leukemia.
Padró T; Ruiz S; Bieker R; Bürger H; Steins M; Kienast J; Büchner T; Berdel WE; Mesters RM
Blood; 2000 Apr; 95(8):2637-44. PubMed ID: 10753845
[TBL] [Abstract][Full Text] [Related]
20. Day 14 Bone Marrow Evaluation During Acute Myeloid Leukemia Induction in a Real-world Canadian Cohort.
England JT; Saini L; Hogge D; Forrest D; Narayanan S; Power M; Nevill T; Kuchenbauer F; Hudoba M; Szkotak A; Brandwein J; Sanford D
Clin Lymphoma Myeloma Leuk; 2020 Jul; 20(7):e427-e436. PubMed ID: 32201130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
